ANXA1 and atherosclerosis: A protective role has been implicated for ANXA1 in atherosclerosis in a study showing that the ANXA1 synthetic N‐terminal peptide, Ac2‐26, is able to reduce neutrophil and monocyte‐mediated atherosclerotic plaque formation [61].